Pancreatic Cancer Clinical Trials

1973 clinical trials for Pancreatic Cancer across international registries, including 300 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma — RECRUITING · PHASE3
• A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma — RECRUITING
• YMN-136 Vaccine for Patients With Advanced Hepatobiliary and Pancreatic Malignancies — RECRUITING · PHASE1
• Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers — RECRUITING · PHASE1
• Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients — RECRUITING · PHASE1
• A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors — RECRUITING · PHASE1
• ToPanc Trial: Survival After Total Versus Partial Pancreaticoduodenectomy for Adenocarcinoma of the Pancreatic Head, Distal Cholangiocarcinoma, and Ampullary Cancer — RECRUITING · NA
• 68Ga-SorB PET/CT Imaging in Patients With Solid Tumors — RECRUITING · NA
• A Study of DM002 in Patients With Advanced Solid Tumors — RECRUITING · PHASE1
• A Study of PHN-012 in Patients With Advanced Solid Tumors — RECRUITING · PHASE1
• Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment — RECRUITING
• A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors — RECRUITING · PHASE1
• A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors — RECRUITING · PHASE1
• IDOV-Immune for Advanced Solid Tumors — RECRUITING · PHASE1
• Distance-Based Exercise to Preserve Function and Prevent Disability — RECRUITING · NA
• A Study of GC203 TIL in PDCA (RJ) — RECRUITING · PHASE1
• A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs — RECRUITING
• Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 ) — RECRUITING · PHASE3
• Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC) — RECRUITING · PHASE3
• KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer — RECRUITING · PHASE1
• Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy in Patients With Cancer-Related Celiac Pain — RECRUITING · NA
• Safety and Efficacy of Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) in the Treatment of Pancreatic Lesions — RECRUITING
• AOH1996 for the Treatment of Refractory Solid Tumors — RECRUITING · PHASE1
• A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer — RECRUITING · PHASE3
• ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer — RECRUITING · PHASE1
• WATD and Cancer-Related Fatigue: A Study For Patients Undergoing Anti-Cancer Treatment — RECRUITING
• A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors — RECRUITING · PHASE1
• DESTINY-PANTUMOUR04 — RECRUITING
• Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer — RECRUITING · NA
• Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma — RECRUITING · PHASE3
• Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients — RECRUITING · NA
• Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy (SBRT) in Participants With Cancer-Related Celiac Pain — RECRUITING · PHASE1
• A Study to Evaluate the Human Biodistribution and Dosimetry of the Radionuclide Labeled IR199 in Patients With Gastric Cancer and Pancreatic Cancer — RECRUITING · PHASE1
• Pancreatic Cancer Detection Consortium — RECRUITING
• Energy Expenditure and Nutrition After Pancreatic Surgery — RECRUITING
• Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors — RECRUITING · PHASE1
• A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors — RECRUITING · PHASE2
• A Study of Magnetic Resonance Imaging of the Pancreas for Cancer Screening — RECRUITING
• Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma (VAPOR2) — RECRUITING
• The HistoSonics Edison™ System for Treatment of Pancreatic Adenocarcinoma Using Histotripsy — RECRUITING · NA
• Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma — RECRUITING · PHASE1
• A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors — RECRUITING · PHASE1
• Hypofractionated Radiotherapy +Chemotherapy+ Camrelizumab as Neoadjuvant Therapy for Pancreatic Cancer — RECRUITING · PHASE2
• A Study on a Predictive Model for Efficacy and Prognosis of Pancreatic Carcinoma Based on Multimodal Data — RECRUITING
• EXoPERT EMERALD Clinical Study — RECRUITING
• Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer — RECRUITING · PHASE1
• Integrated Cancer Repository for Cancer Research — RECRUITING
• Pancreatic Cancer Screening Using the Enzeavour Assay in Japan — RECRUITING · NA
• A Study of ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic Cancer — RECRUITING · PHASE1
• Spatial Multi-omics and Intelligent Early Warning of Pancreatic Cancer Cachexia — RECRUITING

Refine this search